Kyoto, Japan

Akitsu Hotta

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.6

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Akitsu Hotta: Innovator in Immunotherapy

Introduction

Akitsu Hotta is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of immunotherapy, particularly through his innovative methods involving pluripotent stem cells. With a total of 4 patents to his name, Hotta's work is paving the way for advancements in medical treatments.

Latest Patents

One of his latest patents is a method for inducing T cells for cell-based immunotherapy from pluripotent stem cells. This method outlines a process that enhances the efficacy of immunotherapy treatments. Another notable patent involves virus-like particles, which encapsulate a target protein. This invention includes a Gag protein that forms a dimer with the target protein, showcasing Hotta's innovative approach to therapeutic development.

Career Highlights

Throughout his career, Akitsu Hotta has worked with esteemed institutions such as Kyoto University and Thyas Co. Ltd. His research has focused on harnessing the potential of stem cells and virus-like particles to improve immunotherapy outcomes. His contributions have been instrumental in advancing the understanding and application of these technologies in medicine.

Collaborations

Hotta has collaborated with notable colleagues, including Shin Kaneko and Hiroshi Kawamoto. These partnerships have further enriched his research and development efforts, leading to groundbreaking innovations in the field.

Conclusion

Akitsu Hotta's work exemplifies the spirit of innovation in the realm of immunotherapy. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes. His contributions are likely to have a lasting impact on the future of immunotherapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…